Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis - a population-based study.


Journal

Acta oncologica (Stockholm, Sweden)
ISSN: 1651-226X
Titre abrégé: Acta Oncol
Pays: England
ID NLM: 8709065

Informations de publication

Date de publication:
Oct 2022
Historique:
pubmed: 1 10 2022
medline: 22 11 2022
entrez: 30 9 2022
Statut: ppublish

Résumé

Self-reported sex problems among women diagnosed with reproductive and nonreproductive cancers before the age of 40 are not fully understood. This study aimed to determine sexual dysfunction in young women following a cancer diagnosis in relation to women of the general population. Furthermore, to identify factors associated with sexual dysfunction in women diagnosed with cancer. A population-based cross-sectional study with 694 young women was conducted 1.5 years after being diagnosed with cancer (response rate 72%). Potential participants were identified in national quality registries covering breast and gynecological cancer, lymphoma and brain tumors. The women with cancer were compared to a group of women drawn from the general population ( The majority of the women with cancer (83%) as well as the women from the comparison group (87%) reported having had sex the last month (partner sex and/or masturbation). More than 60% of the women with cancer (all diagnoses) reported sexual dysfunction in at least one of the measured domains. The women with cancer reported statistically significantly more problems than women of the comparison group across domains such as decreased interest in having sex, and vaginal and vulvar discomfort. Women with gynecological or breast cancer and those receiving more intense treatment were at particular high risk of sexual dysfunction (≥2 domains). Concurrent emotional distress and body image disturbance were associated with more dysfunction. The results underscore the need to routinely assess sexual health in clinical care and follow-up. Based on the results, development of interventions to support women to cope with cancer-related sexual dysfunction is recommended.

Sections du résumé

BACKGROUND UNASSIGNED
Self-reported sex problems among women diagnosed with reproductive and nonreproductive cancers before the age of 40 are not fully understood. This study aimed to determine sexual dysfunction in young women following a cancer diagnosis in relation to women of the general population. Furthermore, to identify factors associated with sexual dysfunction in women diagnosed with cancer.
MATERIALS AND METHODS UNASSIGNED
A population-based cross-sectional study with 694 young women was conducted 1.5 years after being diagnosed with cancer (response rate 72%). Potential participants were identified in national quality registries covering breast and gynecological cancer, lymphoma and brain tumors. The women with cancer were compared to a group of women drawn from the general population (
RESULTS UNASSIGNED
The majority of the women with cancer (83%) as well as the women from the comparison group (87%) reported having had sex the last month (partner sex and/or masturbation). More than 60% of the women with cancer (all diagnoses) reported sexual dysfunction in at least one of the measured domains. The women with cancer reported statistically significantly more problems than women of the comparison group across domains such as decreased interest in having sex, and vaginal and vulvar discomfort. Women with gynecological or breast cancer and those receiving more intense treatment were at particular high risk of sexual dysfunction (≥2 domains). Concurrent emotional distress and body image disturbance were associated with more dysfunction.
CONCLUSION UNASSIGNED
The results underscore the need to routinely assess sexual health in clinical care and follow-up. Based on the results, development of interventions to support women to cope with cancer-related sexual dysfunction is recommended.

Identifiants

pubmed: 36176069
doi: 10.1080/0284186X.2022.2112283
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1165-1172

Auteurs

Lena Wettergren (L)

Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

Lars E Eriksson (LE)

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
School of Health and Psychological Sciences, City, University of London, London, United Kingdom.
Medical Unit Infectious Diseases, Karolinska University Hospital, Huddinge, Sweden.

Charlotta Bergström (C)

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Department of Surgery and Urology, Danderyd University Hospital, Sweden.

Christel Hedman (C)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
R & D department, Stockholms Sjukhem Foundation, Stockholm, Sweden.
Division of Palliative Care, Department of Clinical Sciences Lund, Lund University, Sweden.

Johan Ahlgren (J)

Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Regional cancer centre, Mid-Sweden, Uppsala, Sweden.

Karin E Smedby (KE)

Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
Center for Hematology, Karolinska University Hospital, Stockholm, Sweden.

Kristina Hellman (K)

Department of Gynecologic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.

Roger Henriksson (R)

Department of Radiation Science and Oncology, University Hospital, Umeå, Sweden.

Claudia Lampic (C)

Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Department of Psychology, Umeå University, Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH